Why drug-eluting stents may not work for most patients with leg ischemia caused by below-knee arterial occlusive disease

Vascular Disease Management

Volumn 5, Issue 5, 2008, Pages 140-142

  Bosiers, Marc ^a   Deloose, Koen ^a   Verbist, Jurgen ^b   Peeters, Patrick ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ANGIOGRAPHY; BLEEDING; DRUG ELUTING STENT; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; KNEE; LEG ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RESTENOSIS; REVASCULARIZATION; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 51849091121     PISSN: 15538036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: Early and one-year outcomes. Am Coll Cardiol 2004;44:2307-2314.
2. Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005;12:685-695.
3. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2006;2:169-174.
4. Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: Early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino) 2006;47:171-176.
5. Commeau P, Barragan P, Roquebert P. Sirolimus for below the knee lesions: Mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006;68:793-798.
6. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: Enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007;14:241-250.
7. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: Midterm angiographic and clinical results. J Vasc Interv Radiol 2007;18:1351-1361.
8. Sakurai R, Ako J, Morino Y, et al. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 2005;96:1251-1253.
9. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
10. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-168.
11. Waksman R. Update on bioabsorbable stents: From bench to clinical. J Interv Cardiol 2006;19:414-421.
12. Harper R. Drug-eluting stents coronary stents - a note of caution. Med J Aust 2007;186:253-255.